AnswersNow is a technology company.
AnswersNow has raised $11.0M across 1 funding round.
AnswersNow has raised $11.0M in total across 1 funding round.
AnswersNow has raised $11.0M in total across 1 funding round.
AnswersNow's investors include Left Lane Capital.
AnswersNow is a digital health company providing virtual Applied Behavior Analysis (ABA) therapy for children with autism spectrum disorder (ASD) via a proprietary telehealth platform.[1][2][5] It serves families seeking accessible, high-quality care without waitlists or commutes, solving barriers like geographic limitations, in-person disruptions (e.g., during COVID-19), and clinician shortages by delivering customized, evidence-based sessions from expert-level board-certified clinicians (master’s/PhD with 1,000+ supervised hours).[1][2][5] The platform enables rapid onboarding (assessment to therapy in as little as 3 weeks), accepts major insurances including Medicaid, and reports 97% of parents noting dramatic improvements in socially significant behaviors; venture-backed with $1.8M seed funding, it's scaling nationally from its Richmond, VA headquarters with a fully remote team.
1
2
3
Founded in 2017 (with some sources noting 2016) by Jeff Beck (LCSW, CEO & Co-Founder) and Adam Dreyfus (BCBA), AnswersNow began as a direct parent-clinician hotline for autism support, operating for two years before pivoting during the 2020 COVID-19 pandemic.[1][2][4] The founders, leveraging their clinical expertise, recognized an opportunity to adapt their existing system into a full tele-ABA platform launched in June 2020, ensuring uninterrupted care amid halted in-person services.[1] Early traction came from delivering thousands of therapy hours, securing funding from Blue Heron Capital and others, and expanding from crisis support to comprehensive virtual therapy.[2][3]
AnswersNow rides the telehealth boom in behavioral health, particularly post-COVID demand for virtual ABA amid clinician shortages and autism diagnosis surges (ripe for disruption per 2025 reports).[1][4] Timing aligns with payer expansions (e.g., Medicaid coverage) and digital health maturation, enabling nationwide scale where in-person ABA waits can exceed months.[2][5] Market forces like insurance parity laws and VC interest in digital therapeutics favor it, as does its private equity backing (Blue Heron Capital).[3] It influences the ecosystem by proving tele-ABA efficacy, reducing access inequities, and inspiring platform-based models in neurodevelopmental care.[1][2]
AnswersNow is poised for accelerated national expansion, building on seed funding, advisory board launch (July 2025), and pre-IPO trading interest to enhance platform AI, clinician networks, and insurance integrations.[3][4] Trends like autism prevalence growth, telehealth reimbursement stability, and payer disruptions will propel it, potentially evolving into a full autism lifecycle platform (diagnosis-to-adulthood). Its clinician-led model positions it to lead virtual ABA consolidation, amplifying impact for underserved families while delivering strong returns for backers like Blue Heron—exemplifying how telehealth unlocks equitable care at scale.[1][2][4]
AnswersNow has raised $11.0M across 1 funding round. Most recently, it raised $11.0M Series A in February 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2023 | $11.0M Series A | Left Lane Capital |